impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

One year in review

 

One year in review 2021: novelties in the treatment of rheumatoid arthritis

1, 2, 3, 4, 5, 6, 7

 

  1. Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna, Cona, Ferrara, Italy.
  2. University of Pavia, Istituti Clinici Scientifici Maugeri IRCCS Pavia, Italy.
  3. Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna, Cona, Ferrara, Italy.
  4. Rheumatology Unit, Department of Medicine, University of Verona, Policlinico G. B. Rossi, Verona, and Division of Rheumatology, University of Padova, Italy.
  5. Rheumatology Division, Multispecialist Medical Department, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  6. Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna, Cona, Ferrara, Italy.
  7. Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna, Cona, Ferrara, and Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy. scrcll@unife.it

CER14813
2021 Vol.39, N°4
PI 0705, PF 0720
One year in review

Free to view
(click on article PDF icon to read the article)

PMID: 34238403 [PubMed]

Received: 17/05/2021
Accepted : 14/06/2021
In Press: 05/07/2021
Published: 08/07/2021

Abstract

Management of rheumatoid arthritis (RA) has evolved over the years as a result of better understanding of the role of different therapeutic strategies, as well as following an increasing availability of new disease-modifying antirheumatic drugs. However, the role of patients in sharing decisions, as well as the rules informing precision medicine or the principles to follow in case of specific comorbidities or extra-articular manifestations are still areas for improvement. Moreover, in 2020, the novel Coronavirus disease-19 outbreak has completely changed many attitudes in terms of assessment and treatment paradigms in most clinical diseases, including RA. In this narrative review, the authors report their specific point of view on the management of RA, based on a critical revision of literature published in 2020, focusing on relevant novelties and future research directions.

DOI: https://doi.org/10.55563/clinexprheumatol/beucf1

Rheumatology Article